Background: Halotherapy is a treatment modality suggested for patients with chronic pulmonary diseases. In this technique, inhalation of crystal salt stones extracted from mines improves patients' pulmonary function tests and symptoms by facilitating the secretion or expulsion of phlegm and mucus and reducing the risk of bacterial infections. Bronchiectasis is chronic disease of the airways characterized by irreversible dilation of airways. It has a progressive course and despite the available treatments, many of these patients eventually enter the advanced phase of disease. The aim of this study was to evaluate the effect of halotherapy on pulmonary function tests and quality of life of non-CF bronchiectatic patients.
in the United States and 37/100,000 in Finland (6, 7) . This disease is idiopathic in 50 to 80% of cases. Other suggested etiologies include viral, bacterial and fungal infections, chronic obstructive pulmonary disease, airway obstruction due to various causes, inhalation of burning substances, foreign body aspiration, allergic bronchopulmonary aspergillosis, amyloidosis, Celiac disease, immunologic disorders, and congenital disorders (8-10). Respiratory physiotherapy, inhaled mucolytic drugs, bronchodilators and antibiotics are the treatment options available for this condition to control infection and facilitate the secretion or expulsion of phlegm and mucus (11) (12) (13) (14) (15) . However, the disease usually has a progressive course and despite the above-mentioned treatments many patients eventually enter the advanced phase of pulmonary disease and may require invasive treatments such as surgery or even lung transplantation (16) 
MATERIALS AND METHODS

RESULTS
Of 40 understudy patients, 20 were excluded from the study (9 subjects due to not correctly using the drug in the mentioned time period, one subject due to respiratory infections, 2 due to hospitalization during the study period for reasons other than drug consumption, one due to drug side effect of severe xerostomia and 7 because of not showing up after the completion of treatment course for retesting). A total of 20 subjects were statistically analyzed out of which 10 were males and 10 were females. The mean (±SD) age of patients was 35 ± 11 years (range 20-53 years) and 12 patients were married. In terms of level of education, 2 were illiterate, 9 were below high school diploma, 5 had high school diploma and 4 had educational level higher than high school diploma. Table 2) . No statistically significant difference was found in the results of 6-minute walk test before and after the intervention (P>0.05)( Table 2 ). The understudy treatment method caused no change in any of the SF-36 quality of life questionnaire scales of patients (P>0.05)( Table 3) . Also, no important side effects such as bronchospasm requiring discontinuation of treatment were observed during the study. Only one patient had to discontinue the drug because of severe xerostomia. Xerostomia occurred in 5 other patients as well but was alleviated or completely resolved by taking some measures and a few recommendations given to patients and thus, the need for discontinuation of drug was obviated. In general, 13 patients (65%) were satisfied with halotherapy and asked for re-administration of drug, 2 (10%) believed that it is ineffective and 5 (25%) were not satisfied with it. Not correctly or regularly using the drug during the study period 9 subjects A total of 20 subjects Thus, future studies with a larger sample size and longer duration are required to illuminate the efficacy of this treatment modality.
